Association Between Vitamin D Receptor Gene FokI Polymorphism and Skeletal Fluorosis of the Brick-tea Type Fluorosis: a Cross Sectional, Case Control Study
Overview
Authors
Affiliations
Background: Brick-tea type fluorosis is a public health concern in the north west area of China. The vitamin D receptor (VDR)-FokI polymorphism is considered to be a regulator of bone metabolism and calcium resorption. However, the association of VDR-FokI polymorphism with the risk of brick-tea type fluorosis has not been reported.
Materials And Methods: A cross sectional, case control study was conducted in three provinces (Inner Mongolia, Qinghai and Sinkiang) in China. The fluoride content of Brick-tea water and urine was tested using the standards GB 1996-2005 and WS/T89-2006 (China), respectively. Skeletal fluorosis was diagnosed using the standard WS/192-2008 (China). The VDR-FokI polymorphism was detected by the Sequenom MassARRAY system.
Result: Compared with carriers of the CC genotype, participants with the CT/TT genotype had a significantly decreased risk of skeletal fluorosis (OR=0.761 (95% CI 0.580 to 0.997)), after adjustment for risk factors. When investigated among ethnic groups, the protective effect of the CT/TT genotype was limited in the Mongolian participants (OR=0.525 (95% CI 0.278 to 0.991)). Moreover, the interaction of VDR-FokI with risk factors was only found in Mongolian participants: the protective effect of the CT/TT genotype was limited to participants with >7.0 mg/day daily intake of tea fluoride (OR=0.085 (95% CI 0.009 to 0.851), participants with >3.2 mg/L urine fluoride (OR=0.103 (95% CI 0.017 to 0.633)) or participants aged 46-65 years (OR=0.404 (95% CI 0.177 to 0.922).
Conclusions: Our data suggest that the CT/TT genotype of VDR-FokI may be a protective factor for brick-tea type skeletal fluorosis, and this effect is pronounced in Mongolian participants.
Brick tea consumption and its relationship with fluorosis in Tibetan areas.
Wen C, Zhang Q, Xie F, Jiang J Front Nutr. 2022; 9:1030344.
PMID: 36583212 PMC: 9792988. DOI: 10.3389/fnut.2022.1030344.
Tao N, Li L, Chen Q, Sun Z, Yang Q, Cao D Front Public Health. 2022; 10:849173.
PMID: 35646794 PMC: 9140744. DOI: 10.3389/fpubh.2022.849173.
Fatturi A, Menoncin B, Reyes M, Meger M, Scariot R, Brancher J Clin Oral Investig. 2020; 24(11):3971-3980.
PMID: 32236726 DOI: 10.1007/s00784-020-03263-y.
Munkhbayarlakh S, Kao H, Hou Y, Tuvshintur N, Bayar-Ulzii B, Narantsetseg L World Allergy Organ J. 2019; 12(11):100076.
PMID: 31719947 PMC: 6838943. DOI: 10.1016/j.waojou.2019.100076.